Pfizer Inc. (FRA:PFEB)

Germany flag Germany · Delayed Price · Currency is EUR
7.20
-0.10 (-1.37%)
At close: Feb 20, 2026
Market Cap128.61B -10.6%
Revenue (ttm)53.30B -1.6%
Net Income6.62B -3.2%
EPS1.16 -3.4%
Shares Outn/a
PE Ratio19.43
Forward PE8.96
Dividend0.48 (6.72%)
Ex-Dividend DateJan 23, 2026
Volumen/a
Average Volume47
Open7.20
Previous Close7.30
Day's Range7.20 - 7.20
52-Week Range5.80 - 7.95
Betan/a
RSI52.36
Earnings DateApr 28, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PFEB
Full Company Profile

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD Financial Statements